Skip to Main Content

Good morning, everyone, and how are you today? We are just fine, thank you, as we brace ourselves for a looming snowstorm. The shovels, the salt, and, yes, the cups of stimulation are already handy. Meanwhile, though, there is much to do as meetings, deadlines, and whatnot await. No doubt, you can relate. So here are a few tidbits to pave the way. Have a smashing day and do keep in touch …

The Food and Drug Administration’s Office of Prescription Drug Promotion sent Pfizer’s Hospira subsidiary a letter because the drug maker ran a “misleading” YouTube video for a sedative known as Precedex. According to the letter, there were many claims in the video about effectiveness, but there was no mention of negative side effects, which created “a misleading impression about the drug’s safety.”


Zhejiang Hisoar Pharmaceutical, which is based in China and makes ingredients for some of the world’s biggest brand-name drug makers, was banned by the FDA from shipping its products to the United States, Bloomberg News writes. An agency inspection last August found quality-control records were deleted and test records had been altered, and failing test results sometimes went unreported.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!